EUVIMEDEUVIMED entdecken
Crossref

A Novel Polymer Nanoparticle Polydimethyl Diallyl Ammonium Chloride as An Adjuvant Enhances the Immune Response of SARS‐CoV‐2 Subunit Vaccine

Lili Ren iD, Chengcheng Ouyang, Shuqing Zhao, Qiqi Zheng, Weilu Guo, Baochao Fan, Jinzhu Zhou, Wei Zhang, Mi Hu, Jizong Li, Bin Li

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202304575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Lili Ren und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanjing Tech University, Nanjing, 211816, China. Hauptthemen laut MEDLINE: Nanoparticles, COVID-19 Vaccines, SARS-CoV-2, Vaccines, Subunit. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Key Research and Development Program, Science and Technology Planning Project of Jiangsu Province of China, Jiangsu province Natural Sciences Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Coronavirus Disease 2019 (COVID‐19) pandemic caused by SARS‐CoV‐2 has a significant impact on global health and the economy. It has underscored the urgent need for a stable, easily produced and effective vaccine. This study presents a novel approach using SARS‐CoV‐2 spike (S) protein‐conjugated nanoparticles (NPs) in combination with cyclic GMP‐AMP (cGAMP) (S‐NPs‐cGAMP) as a subunit vaccine. When mice are immunized, the antiserum of S‐NPs‐cGAMP group exhibits a 16‐fold increase in neutralizing activity against a pseudovirus, compared to S protein group. Additionally, S‐NPs‐cGAMP induces even higher levels of neutralizing antibodies. Remarkably, the vaccine also triggers a robust humoral immune response, as evidenced by a notable elevation in virus‐specific IgG and IgM antibodies. Furthermore, after 42 days of immunization, there is an observed increase in specific immune cell populations in the spleen. CD3 + CD4 + and CD3 + CD8 + T lymphocytes, as well as B220 + CD19 + and CD3 − CD49b + NK lymphocytes, show an upward trend, indicating a positive cellular immune response. Moreover, the S‐NPs‐cGAMP demonstrates promising results against the Delta strain and exhibits good cross‐neutralization potential against other variants. These findings suggest that pDMDAAC NPs is potential adjuvant and could serve as a versatile platform for future vaccine development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesCOVID-19 VaccinesSARS-CoV-2Vaccines, SubunitSpike Glycoprotein, CoronavirusCOVID-19AnimalsMiceFemaleAntibodies, NeutralizingMice, Inbred BALB CAntibodies, ViralAdjuvants, ImmunologicHumansImmunity, HumoralAdjuvants, VaccineQuaternary Ammonium CompoundsPolymers

Stichwörter der Autor:innen

SARS‐CoV‐2adjuvantpolydimethyl diallyl ammonium chloridesubunit vaccine

Substanzen

COVID-19 VaccinesVaccines, SubunitSpike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralAdjuvants, Immunologicspike protein, SARS-CoV-2Adjuvants, VaccineQuaternary Ammonium CompoundsPolymers

Autor:innen und Institutionen

  • School of Pharmacy, Nanjing Tech University, Nanjing, 211816, China.
  • Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Key Laboratory of Veterinary Biological Engineering and Technology Ministry of Agriculture, Jiangsu Key Laboratory for Food Quality and Safety-…
  • Institute of Life Sciences, School of Food and Biological Engineering, Jiangsu University, Zhenjiang, 212013, China.
  • Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonose, Yangzhou University, Yangzhou, 225009, P. R. China.
  • College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China.

ORCID-Profile: Lili Ren

Förderung

  • National Key Research and Development Program
  • Science and Technology Planning Project of Jiangsu Province of China
  • Jiangsu province Natural Sciences Foundation
  • Jiangsu Agriculture Science and Technology Innovatioin Fund
  • National Natural Science Foundation of China
  • Animal Ethics Committee of Nanjing Tech University
  • National Key Research and Development Program of China

Zitieren

APA

Ren, L., Ouyang, C., Zhao, S., Zheng, Q., Guo, W., Fan, B., Zhou, J., Zhang, W., Hu, M., Li, J., & Li, B. (2024). A Novel Polymer Nanoparticle Polydimethyl Diallyl Ammonium Chloride as An Adjuvant Enhances the Immune Response of SARS‐CoV‐2 Subunit Vaccine. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202304575

Vancouver

Ren L, Ouyang C, Zhao S, Zheng Q, Guo W, Fan B, et al. A Novel Polymer Nanoparticle Polydimethyl Diallyl Ammonium Chloride as An Adjuvant Enhances the Immune Response of SARS‐CoV‐2 Subunit Vaccine. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202304575

BibTeX
@article{Ren2024,
  author = {Ren, Lili and Ouyang, Chengcheng and Zhao, Shuqing and Zheng, Qiqi and Guo, Weilu and Fan, Baochao and Zhou, Jinzhu and Zhang, Wei and Hu, Mi and Li, Jizong and Li, Bin},
  title = {A Novel Polymer Nanoparticle Polydimethyl Diallyl Ammonium Chloride as An Adjuvant Enhances the Immune Response of SARS‐CoV‐2 Subunit Vaccine},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202304575}
}
Kostenlos starten →